Why High Court May Have Rejected IP Obviousness Appeal
In February, Vanda Pharmaceuticals Inc. submitted a petition to the U.S. Supreme Court that challenged the U.S. Court of Appeals for the Federal Circuit's reasonable expectation of success, or RES, standard...To view the full article, register now.
Already a subscriber? Click here to view full article